Search Within

Ashley Regazzi

Formats
  1. Meeting Abstract (59)
  2. Journal Article (34)
Groups
  1. Department of Medicine (93)
  2. Genitourinary Oncology Service (93)
  3. Solid Tumor Oncology Division (93)
  4. Epidemiology and Biostatistics (53)
  5. Biostatistics Service (51)
  6. Department of Pathology and Laboratory Medicine (43)

More Groups

People
  1. Dean Bajorin (80)
  2. Jonathan Rosenberg (70)
  3. Gopakumar Iyer (58)
  4. Irina Ostrovnaya (47)
  5. Samuel Funt (40)
  6. Hikmat Al-Ahmadie (38)

More People

Years
  1. 2025 (7)
  2. 2024 (7)
  3. 2023 (5)
  4. 2022 (10)
  5. 2021 (9)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (66)
  2. Clinical Genitourinary Cancer (7)
  3. JCO Precision Oncology (3)
  4. Cancer (2)
  5. Annals of Oncology (1)
  6. BJU International (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. Elsevier Inc. (7)
  3. Wiley Blackwell (4)
  4. American Association for Cancer Research (2)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (93)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DNA damage repair (DDR) germline mutations in patients (Pts) with urothelial carcinoma (UC)
    Meeting Abstract

    Carlo, M. I.; Vijai, J.; Mandelker, D.; Kemel, Y.; Regazzi, A. M.; Zhang, L.; Stadler, Z. K.; Walsh, M. F.; Cadoo, K. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pre-operative chemotherapy (ctx) in plasmacytoid urothelial carcinoma (PUC)
    Meeting Abstract

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Dalbagni, G.; Bochner, B. H.; Funt, S.; Iyer, G.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nomogram to assess the survival benefit of new salvage agents for metastatic urothelial carcinoma in the era of immunotherapy
    Journal Article

    Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Choueiri, T. K.; Bellmunt, J.; Regazzi, A. M.; Mullane, S. A.; Necchi, A.; Raggi, D.; Lee, J. L.; more...
    Clinical Genitourinary Cancer (2018)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer
    Journal Article

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers
    Journal Article

    Teo, M. Y.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Kania, B. E.; Moran, M. M.; Cipolla, C. K.; Bluth, M. J.; Chaim, J.; Al-Ahmadie, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nomogram to assess survival benefit of new over historical agents as salvage therapy for metastatic urothelial carcinoma (mUC) in non-randomized trials
    Meeting Abstract

    Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Choueiri, T. K.; Bellmunt, J.; Regazzi, A. M.; Mullane, S. A.; Necchi, A.; Raggi, D.; Lee, J. L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder
    Journal Article

    Alanee, S. R.; Shah, S.; Zabor, E. C.; Vijai, J.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Pendse, D. V.; Littman, J.; Regazzi, A. M.; Offit, K.; more...
    International Journal of Clinical Pharmacology and Therapeutics (2017)

    Fulltext@MSK | Save
  • Correlation of DNA damage response (DDR) gene alterations with response to neoadjuvant (neo) dose-dense gemcitabine and cisplatin (ddGC) in urothelial carcinoma (UC)
    Meeting Abstract

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation of peripheral and intratumoral T-cell receptor (TCR) clonality with clinical outcomes in patients with metastatic urothelial cancer (mUC) treated with atezolizumab
    Meeting Abstract

    Funt, S.; Charen, A. S.; Yusko, E.; Vignali, M.; Benzeno, S.; Boyd, M. E.; Moran, M. M.; Kania, B. E.; Cipolla, C. K.; Regazzi, A. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I study of everolimus in combination with gemcitabine and split-dose cisplatin in advanced urothelial carcinoma
    Journal Article

    Abida, W.; Milowsky, M. I.; Ostrovnaya, I.; Gerst, S. R.; Rosenberg, J. E.; Voss, M. H.; Apolo, A. B.; Regazzi, A. M.; McCoy, A. S.; Boyd, M. E.; more...
    Bladder Cancer (2016)

    Fulltext@MSK | Save